These authors contributed equally to this work.
The effect of one additional driver mutation on tumor progression
Article first published online: 10 DEC 2012
© 2012 The Authors. Evolutionary Applications published by Blackwell Publishing Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Special Issue: Evolution and Cancer
Volume 6, Issue 1, pages 34–45, January 2013
Total views since publication: 844
How to Cite
Reiter, J. G., Bozic, I., Allen, B., Chatterjee, K. and Nowak, M. A. (2013), The effect of one additional driver mutation on tumor progression. Evolutionary Applications, 6: 34–45. doi: 10.1111/eva.12020
- Issue published online: 21 JAN 2013
- Article first published online: 10 DEC 2012
- Manuscript Accepted: 6 SEP 2012
- Manuscript Received: 15 JUN 2012
- 1990. In vivo somatic mutations in humans: measurement and analysis. Annual Review of Genetics 24:305–326. , , , and
- 1992. Breast carcinoma growth rate described by mammographic doubling time and S-phase fraction. Correlations to clinical and histopathologic factors in a screened population. Cancer 70:1928–1934. , , , , , , et al.
- 2011. Exact solution of a two-type branching process: models of tumor progression. Journal of Statistical Mechanics, P08018. , and
- 1954. The age distribution of cancer and a multi-stage theory of carcinogenesis. British Journal of Cancer 8:1–12. , and
- 1972. Branching Processes. Springer-Verlag, Berlin. , and
- 2010. A mathematical framework to determine the temporal sequence of somatic genetic events in cancer. Proceedings of the National Academy of Sciences of the United States of America 107:17604–17609. , , , , , et al.
- 1989. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244:217–221. , , , , , , et al.
- 2009). Mutator mutations enhance tumorigenic efficiency across fitness landscapes. PLoS One 4:e5860. (
- 2007. Genetic progression and the waiting time to cancer. PLoS Computational Biology 3:e225. , , , , , , et al.
- 2010. Accumulation of driver and passenger mutations during tumor progression. Proceedings of the National Academy of Sciences of the United States of America 107:18545–18550. , , , , , , et al.
- 2012. Dynamics of targeted cancer therapy. Trends in Molecular Medicine 18:311–316. , , and
- 2002. Embryonic stem cells and somatic cells differ in mutation frequency and type. Proceedings of the National Academy of Sciences of the United States of America 99:3586. , , , , and
- 2007. A single type of progenitor cell maintains normal epidermis. Nature 446:185–189. , , , , , and
- 1985. Role of mathematical modeling in protocol formulation in cancer chemotherapy. Cancer Treatment Reports 69:1041–1048. , and
- 1986. A stochastic model for the origin and treatment of tumors containing drug-resistant cells. Bulletin of Mathematical Biology 48:279–292. , and
- 1983. A model for the resistance of tumor cells to cancer chemotherapeutic agents. Mathematical Biosciences 65:291–307. , and
- 2005. A generalized luria–delbrück model. Mathematical Biosciences 197:140–152. , , and
- 2012. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 486:537–540. , , , , , , et al.
- 2006. Successful therapy must eradicate cancer stem cells. Stem Cells 24:2603–2610. , and
- 2011. Traveling waves of selective sweeps. The Annals of Applied Probability 21:699–744. ISSN: 1050-5164. , and
- 2010. Evolution of resistance and progression to disease during clonal expansion of cancer. Theoretical Population Biology 77:42–48. , and
- 2011. Intratumor heterogeneity in evolutionary models of tumor progression. Genetics 188:461–477. , , , , and
- 1990. A genetic model for colorectal tumorigenesis. Cell 61:759–767. , and
- 2010. Evolution of resistance to anti-cancer therapy during general dosing schedules. Journal of Theoretical Biology 263:179–188. , and
- 2004. Problems of somatic mutation and cancer. BioEssays 26:291–299. , and
- 1997. On the growth rates of human malignant tumors: implications for medical decision making. Journal of Surgical Oncology 65:284–297. , and
- 2008. A microenvironmental model of carcinogenesis. Nature Reviews Cancer 8:56–61. , and
- 2010. Waiting time models of cancer progression. Mathematical Population Studies 17:115–135. , and
- 2011. The temporal order of genetic and pathway alterations in tumorigenesis. PLoS One 6:e27136. , , , , and
- 1979. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer treatment reports 63:1727. , and
- 1986. Application of theoretical models to chemotherapy protocol design. Cancer Treatment Reports 70:127–131. , and
- 1998. Drug Resistance in Cancer: Mechanisms and Models. Cambridge University Press, New York. , and
- 2007. Patterns of somatic mutation in human cancer genomes. Nature 446:153–158. , , , , , , and et al.
- 2000. The hallmarks of cancer. Cell 100:57–70 , and
- 2011. The hallmarks of cancer: the next generation. Cell 144:646–674. , and
- 1979. Cell kinetic analyses of human malignant brain tumors (gliomas). Cancer 44:956–962. , and
- 2011. Evolutionary dynamics of intratumor heterogeneity. PLoS One 6:e17866. , and
- 2004. Stochastic tunnels in evolutionary dynamics. Genetics 166:1571–1579. , , and
- 2005. Population genetics of tumor suppressor genes. Journal of Theoretical Biology 233:15–23. , , , and
- 2006. Evolution of resistance during clonal expansion. Genetics 172:2557–2566. , , and
- 2005. A multiscale model for avascular tumor growth. Biophysical Journal 89:3884–3894. , , , and
- 2008a. Comparative lesion sequencing provides insights into tumor evolution. Proceedings of the National Academy of Sciences of the United States of America 105:4283–4288. , , , , , , et al.
- 2008b. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses. Science 321:1801–1806. , , , , , , et al.
- 2000. Tumor angiogenesis: past, present and the near future. Carcinogenesis 21:505–515.
- 1996. Lessons from hereditary colorectal cancer. Cell 87:159–170. , and
- 2010. Stochastic fate of p53-mutant epidermal progenitor cells is tilted toward proliferation by UV B during preneoplasia. Proceedings of the National Academy of Sciences of the United States of America 107:270–275. , , , and
- 1971. Statistical study of retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America 68:820–823.
- 2001. Two genetic hits (more or less) to cancer. Nature Reviews Cancer 1:157–162.
- 2005. Drug resistance in cancer: principles of emergence and prevention. Proceedings of the National Academy of Sciences of the United States of America 102:9714–9719 , and
- 2002. Dynamics of genetic instability in sporadic and familial colorectal cancer. Cancer Biology & Therapy 1:679–686. , , , and
- 2003. Mutation-selection networks of cancer initiation: tumor suppressor genes and chromosomal instability. Journal of Theoretical Biology 223:433–450. , , and
- 1972. The gross rates of growth of human mammary carcinoma. Cancer 30:594–599. , , , , and
- 2011. Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemia. PLoS One 6:e27682. , , , , , and
- 1998. Genetic instabilities in human cancers. Nature 396:643–643. , , , et al.
- 1994. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Research 54:5059–5063.
- 2002. Multistage carcinogenesis and the incidence of colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America 99:15095–15100. , and
- 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28:491–511. , and
- 2004. Selectively advantageous mutations and hitchhikers in neoplasms. Cancer Research 64:3414–3427. , , , , , and
- 2011. Spatial structure increases the waiting time for cancer. New Journal of Physics 13:115014. , , , and
- 2006. Cancer as an evolutionary and ecological process. Nature Reviews Cancer 6:924–935. , , , and
- 2008. Age-specific incidence of cancer: phases, transitions, and biological implications. Proceedings of the National Academy of Sciences of the United States of America 105:16284–9. , , , and
- 2005a. Dynamics of chronic myeloid leukaemia. Nature 435:1267–1270. , , , , , , and et al.
- 2003. Local regulation of homeostasis favors chromosomal instability. Current Biology 13:581–584. , , , and
- 2005b. Can chromosomal instability initiate tumorigenesis? Seminars in Cancer Biology 15:43–49. , , , , and
- 2006. The age incidence of chronic myeloid leukemia can be explained by a one-mutation model. Proceedings of the National Academy of Sciences of the United States of America 103:14931–14934. , , and
- 1981. Mutation and cancer: a model for human carcinogenesis. Journal of the National Cancer Institute 66:1037–52. , and
- 1953. A new theory on the cancer-inducing mechanism. British Journal of Cancer 7:68.
- 2002. The role of chromosomal instability in tumor initiation. Proceedings of the National Academy of Sciences of the United States of America 99:16226–16231. , , , , , , and et al.
- 2003. The linear process of somatic evolution. Proceedings of the National Academy of Sciences of the United States of America 100:14966–14969. , , and
- 2004. Evolutionary dynamics of tumor suppressor gene inactivation. Proceedings of the National Academy of Sciences of the United States of America 101:10635–10638. , , , and
- 2006. Genetic instability and clonal expansion. Journal of Theoretical Biology 241:26–32. , , and
- 1976. The clonal evolution of tumor cell populations. Science 194:23–28.
- 2008. An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807–1812. , , , , , , et al.
- 2003. The significance of unstable chromosomes in colorectal cancer. Nature Reviews Cancer 3:695–701. , , , and
- 2011. The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy. Proceedings of the National Academy of Sciences of the United States of America 108:10871–10877. , , and
- 1961. A biomathematical approach to clinical tumor growth. Cancer 14:1272–1294.
- 2006. The consensus coding sequences of human breast and colorectal cancers. Science 314:268–274. , , , , , , et al.
- 1993. Decelerating growth and human breast cancer. Cancer 71:2013–2019. , , and
- 1963. The frequency distribution of the rates of growth and the estimated duration of primary pulmonary carcinomas. Cancer 16:687–693. , , and
- 1986. A stochastic Gompertz birth-death process. Statistics & Probability Letters 4:25–28.
- 2004. Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis. World Journal of Surgery 28:263–270. , , , , , , et al.
- 1993. Microsatellite instability in cancer of the proximal colon. Science 260:816–819. , , and
- 1993. The multistep nature of cancer. Trends in Genetics 9:138–141. , and
- 2004. Cancer genes and the pathways they control. Nature Medicine 10:789–799. , and
- 1988. Genetic alterations during colorectal-tumor development. New England Journal of Medicine 319:525–532. , , , , , , et al.
- 1974. Tumor doubling time and survival of men with bronchogenic carcinoma. Chest 65:3–8.
- 1963. The rates and patterns of growth of 375 tumors of the large intestine and rectum observed serially by double contrast enema study (Malmoe technique). American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine 90:673–87. , , and
- 2005. Computational Biology of Cancer: Lecture Notes and Mathematical Modeling. World Scientific Pub Co Inc., Singapore. , and
- 2007. The genomic landscapes of human breast and colorectal cancers. Science 318:1108–1113. , , , , , , et al.
- 2010. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467:1114–1117. , , , , , , et al.
- 1999. Progress of a half century in the study of the Luria Delbrück distribution. Mathematical Biosciences 162:1–32.